| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3283802 | Clinical Gastroenterology and Hepatology | 2009 | 7 Pages |
Abstract
Higher HRQOL predicts lower mortality in patients with cirrhosis. This relationship is independent of MELD; MELD does not capture liver-specific HRQOL. Beyond its use as a secondary outcome in clinical trials, HRQOL could be used to predict survival of patients with advanced liver disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Fasiha Kanwal, Ian M. Gralnek, Ron D. Hays, Angelique Zeringue, Francisco Durazo, Steven B. Han, Sammy Saab, Roger Bolus, Brennan M.R. Spiegel,